TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection

Clinical trial NCT03964493 · COMPLETED

Trial details

NCT number: NCT03964493
Sponsor: TenNor Therapeutics Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Skin and Subcutaneous Tissue Bacterial Infections Gram-Positive Bacterial Infections

Start date: 2019-04-20
Primary completion: 2020-09-28
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.